Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

NCT02682264 is registered in ClinicalTrials.gov with Cassiopea SpA as lead sponsor.

NCT NCT02682264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02682264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris
Lead sponsor
Cassiopea SpA
Phase
Phase 3
Overall status
Completed
Start date
March 9, 2016
Completion date
August 31, 2018
Enrollment
609 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris